Compugen (CGEN) Operating Expenses (2009 - 2026)
Compugen (CGEN) posted quarterly Operating Expenses of $9.4 million for Q1 2026, up 13.17% year-over-year from $8.3 million in Q1 2025, and up 20.84% on a QoQ basis from $7.8 million in Q4 2025.
Compugen (CGEN) Operating Expenses (2009 - 2026) Analysis & Trends
Compugen has reported Operating Expenses for 18 years, with the latest figure at $9.4 million in Q1 2026.
- Operating Expenses for Q1 2026 came in at $9.4 million, up 13.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $33.3 million (down 2.57% YoY), and the FY2025 annual result was $32.2 million, down 7.58% from the prior year.
- Operating Expenses improved to $9.4 million in Q1 2026, from $7.8 million in the prior quarter.
- Over five years, Operating Expenses peaked at $13.5 million in Q4 2023 and troughed at $7.8 million in Q4 2025.
- A 5-year average of $9.6 million and a median of $9.4 million in 2026 frame the typical range for Operating Expenses.
- The widest annual swing landed in 2023, when Operating Expenses surged 33.99%; it then sank 38.54% in 2024.
- A 5-year view of Operating Expenses shows it stood at $10.1 million in 2022, then soared by 33.99% to $13.5 million in 2023, then sank by 38.54% to $8.3 million in 2024, then declined by 6.35% to $7.8 million in 2025, then grew by 20.84% to $9.4 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $9.4 million in Q1 2026, $7.8 million in Q4 2025, and $8.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | 9.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.37 Mn |
| Dec 31, 2025 | 7.75 Mn |
| Sep 30, 2025 | 8.13 Mn |
| Jun 30, 2025 | 8.02 Mn |
| Mar 31, 2025 | 8.28 Mn |
| Dec 31, 2024 | 8.28 Mn |
| Sep 30, 2024 | 9.04 Mn |
| Jun 30, 2024 | 8.56 Mn |
| Mar 31, 2024 | 8.95 Mn |
| Dec 31, 2023 | 13.47 Mn |
| Sep 30, 2023 | 10.63 Mn |
| Jun 30, 2023 | 10.21 Mn |
| Mar 31, 2023 | 10.13 Mn |
| Dec 31, 2022 | 10.05 Mn |
| Sep 30, 2022 | 12.21 Mn |
| Jun 30, 2022 | 9.64 Mn |
| Mar 31, 2022 | 10.00 Mn |
| Dec 31, 2021 | 8.78 Mn |
| Sep 30, 2021 | 11.65 Mn |
| Jun 30, 2021 | 9.70 Mn |